All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway

References

• Gallagher DJ and Kemeny N: Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78, 37–48, 2010.
   Web of Science ®Google Scholar
• Rhinn M and Dollé P: Retinoic acid signalling during development. Development 139, 843–858, 2012.
   PubMed Web of Science ®Google Scholar
• Rohde D and Brkovic D: and Hönig d'Orville I: All-trans retinoic acid and interferon-alpha for treatment of human renal cell carcinoma multicellular tumor spheroids. Urol Int 73, 47–53, 2004.
   PubMed Web of Science ®Google Scholar
• Garattini E, Bolis M, Garattini SK, Fratelli M, Centritto F, et al.: Retinoids and breast cancer: from basic studies to the clinic and back again. Cancer Treat Rev 40, 739–749, 2014.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chen YQ, Chen ZM, Chen F, and Su WJ: Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro. Acta Pharmacol Sin 23, 835–841, 2002.
   PubMed Web of Science ®Google Scholar
• Lan L, Cui D, Luo Y, Shi BY, Deng LL, et al.: Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro. J Endocrinol Invest 32, 731–738, 2009.
   PubMed Web of Science ®Google Scholar
• Freemantle SJ, Spinella MJ, and Dmitrovsky E: Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305–7315, 2003.
   PubMed Web of Science ®Google Scholar
• Hansen LA, Sigma CC, Andreola F, Ross SA, Kelloff GJ, et al.: Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21, 1271–1279, 2000.
   PubMed Web of Science ®Google Scholar
• Siddikuzzaman C, Guruvayoorappan  , and Berlin Grace V: All trans retinoic acid and cancer. Immunopharmacol Immunotoxicol 33, 241–249, 2011.
   PubMed Web of Science ®Google Scholar
• Park JS, Koh YS, Bang JY, Jeong YI, and Lee JJ: Antitumor effect of all-trans retinoic acid-encapsulated nanoparticles of methoxy poly(ethylene glycol)-conjugated chitosan against CT-26 colon carcinoma in vitro. J Pharm Sci 97, 4011–4009, 2008.
   PubMed Web of Science ®Google Scholar
• Nguyen DX and Bos PD: and Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274–284, 2009.
   PubMed Web of Science ®Google Scholar
• Rigor RR, Shen Q, Pivetti CD, Wu MH, and Yuan SY: Myosin light chain kinase signaling in endothelial barrier dysfunction. Med Res Rev 33, 911–933, 2013.
   PubMed Web of Science ®Google Scholar
• Zuo L, Lu M, Zhou Q, Wei W, and Wang Y: Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food Chem Toxicol 62, 892–900, 2013.
   PubMed Web of Science ®Google Scholar
• Strong JE, Wong G, Jones SE, Grolla A, Theriault S, et al.: Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway. Proc Natl Acad Sci U S A 105, 17982–17987, 2008.
   PubMed Web of Science ®Google Scholar
• Dridi S, Hirano Y, Tarallo V, Kim Y, Fowler BJ, et al.: ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proc Natl Acad Sci U S A 109, 13781–13786, 2012.
   PubMed Web of Science ®Google Scholar
• Chen C, Diao D, Guo L, Shi M, Gao J, et al.: All-trans-retinoic acid modulates ICAM-1 N-glycan composition by influencing GnT-III levels and inhibits cell adhesion and trans-endothelial migration. PLoS One 7, e52975, 2012.
   PubMed Web of Science ®Google Scholar
• Park EY, Wilder ET, and Lane MA: Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels. Nutr Cancer 57, 66–77, 2007.
   PubMed Web of Science ®Google Scholar
• Early DS and Gray DM: Patient attitudes and issues in colon cancer screening. J Natl Compr Canc Netw 12, 673–678, 2014.
   PubMed Web of Science ®Google Scholar
• Battisti S, Guida FM, Pagliara E, Tonini G, Zobel BB, et al.: Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view. Clin Colorectal Cancer 13, e13–15, 2014.
   PubMedGoogle Scholar
• Totsukawa G, Wu Y, Sasaki Y, Hartshorne DJ, Yamakita Y, et al.: Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts. J Cell Biol 164, 427–439, 2004.
   PubMed Web of Science ®Google Scholar
• Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, et al.: FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6, 154–161, 2004.
   PubMed Web of Science ®Google Scholar
• Shen L: Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci 1258, 9–18, 2012.
   PubMed Web of Science ®Google Scholar
• Miyoshi J and Takai Y: Structural and functional associations of apical junctions with cytoskeleton. Biochim Biophys Acta 1778, 670–691, 2008.
   PubMed Web of Science ®Google Scholar
• Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, et al.: Tight junctions are membrane microdomains. J Cell Sci 113, 1771–1781, 2000.
   PubMed Web of Science ®Google Scholar
• Cunningham KE and Turner JR: Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci 1258, 34–42, 2012.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke E, Mehta D, Minshall R, and Malik AB: Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123, 134–145, 2008.
   PubMed Web of Science ®Google Scholar
• Lum H and Malik AB: Regulation of vascular endothelial barrier function. Am J Physiol 267, L223–241, 1994.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Nagaishi T, Yamazaki M, Onizawa M, and Watabe T: Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis. PLoS One 9, e88369, 2014.
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Guo S, Ye D, and Ma TY: TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1. Am J Pathol 183, 1871–1884, 2013.
   PubMed Web of Science ®Google Scholar
• Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, and Turner JR: MLCK- dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci 107, 8237–8241, 2010.
   PubMed Web of Science ®Google Scholar
• Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, et al.: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137, 481–492, 1997.
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Catling AD, Webb DJ, Sankovic M, and Walker LA: Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 146, 149–164, 1999.
   PubMed Web of Science ®Google Scholar
• Cui J, Gong M, He Y, Li Q, He T, et al.: All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro. Int J Oncol 48, 349–357, 2016.
   PubMed Web of Science ®Google Scholar
• Yan YW, Zhen L, Xu X, Chen C, Wei W, et al.: All-trans retinoic acids induce differentiation and sensitize a radio resistant breast cancer cells to chemotherapy. BMC Complement Altern Med 16, 113–123, 2016.
   PubMed Web of Science ®Google Scholar